What is AIMD stock price today?

AIMD (Ainos Inc) stock is trading at $1.41 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is AIMD stock going up or down today?

AIMD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AIMD stock now?

The decision to buy AIMD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AIMD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AIMD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AIMD stock overvalued or undervalued?

Use our DCF valuation calculator to determine if AIMD is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is AIMD's P/E ratio?

P/E ratio data for AIMD will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is AIMD's market cap?

AIMD (Ainos Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is AIMD's price to book ratio?

AIMD trades at a price-to-book (P/B) ratio of 0.98, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does AIMD pay dividends?

AIMD does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is AIMD's dividend yield?

AIMD does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is AIMD stock a good long-term investment?

AIMD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is AIMD's revenue growth rate?

AIMD has shown revenue growth of 4.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for AIMD are available on our dashboard with complete income statement analysis.

What are the risks of investing in AIMD?

Key risks for AIMD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does AIMD compare to its competitors?

Compare AIMD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize AIMD's performance and positioning.

What is AIMD's stock price target for 2026?

Our AI model provides price targets for AIMD based on fundamental analysis: Bull case $1.83 (+30%), Base case $1.62 (+15%), Bear case $1.27 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about AIMD?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for AIMD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is AIMD's next earnings report?

AIMD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

AIMD - Ainos Inc

NYSE * Health Care * Health Care Equipment & Supplies

$1.41

$-0.05 (-3.42%)

About Ainos Inc

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

AIMD Key Statistics

Market Cap

$12.31M

P/B Ratio

0.98

EPS

$-4.52

Revenue Growth

+4.1%

Employees

How AIMD Compares to Peers

AIMD has the fastest revenue growth among competitors

AIMD is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

N/A

of 1

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
AIMD(This stock)	$12.31M	N/A	4%	0.0%	-
AMZNAmazon Com	$2.23T	29.0	0%	0.1%	vs AMZN

Ainos Inc Company Information

Headquarters: California; U.S.A
Website: www.ainos.com
Sector: Health Care
Industry: Health Care Equipment & Supplies

Data Updated: March 16, 2026 at 4:58 AM EDT

Ready to invest in AIMD?

Commission-free trading available. Affiliate links.

Upcoming Events for AIMD

Dashboard

Enter a ticker to analyze